tirzepatide gout risk and change in uric acid and its association with weight reduction: post hoc analyses of the SURMOUNT-1 randomised placebo-controlled trial Integrated approach to hyperuricemia, gout,

If anything, it appears to protect against it

[9] [12] [17] Developed by Eli Lilly and Company, tirzepatide was approved for treatment of diabetes in the US in May 2022, [9] [12] in the European Union in September 2022, [11] in Canada in November 2022, [18] and in Australia in December 2022

& Boyle, J

The test analyzes GLP1R and GIPR variants that influence your brain's sensitivity to these medications, as well as FTO and MC4R markers linked to stress-eating behavior and anxiety proneness

Last reviewed: June 8, 2026 Last updated: June 8, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations